Results 251 to 260 of about 215,422 (309)

A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis

open access: yesArthritis &Rheumatology, EarlyView.
Objective This study investigated that serum metabolomics, before urate‐lowering therapy (ULT) initiation, could serve as a biomarker for responsiveness to colchicine prophylaxis in patients with gout commencing treat‐to‐target ULT. Methods We studied a multicenter prospective cohort (n = 409) initiating treat‐to‐target ULT plus colchicine prophylaxis.
Wenyan Sun   +13 more
wiley   +1 more source

Routine childhood immunization coverage, timeliness, dropout, and missed opportunities in Northern Ghana: Evidence from a community-based survey in Tamale Metropolis, Ghana. [PDF]

open access: yesPLOS Glob Public Health
Konlan M   +10 more
europepmc   +1 more source

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola   +14 more
wiley   +1 more source

The Dropout

open access: yesAmerican Journal of Pharmaceutical Education, 1966
openaire   +1 more source

A defined community of core gut microbiota members promotes cognitive performance in honey bees. [PDF]

open access: yesProc Natl Acad Sci U S A
Cabirol A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy